Annika Sprussel

Berlin, BE 10178, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis.

Targeting KDM1A in Neuroblastoma with NCL-1 Induces a Less Aggressive Phenotype and Suppresses Angiogenesis.

Journal: Journal of clinical medicine

Published: August 11, 2024

L-Glyceraldehyde Inhibits Neuroblastoma Cell Growth via a Multi-Modal Mechanism on Metabolism and Signaling.

L-Glyceraldehyde Inhibits Neuroblastoma Cell Growth via a Multi-Modal Mechanism on Metabolism and Signaling.

Journal: Cancers

Published: March 28, 2024

Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics.

Circulating Cell-Free DNA Assessment in Biofluids from Children with Neuroblastoma Demonstrates Feasibility and Potential for Minimally Invasive Molecular Diagnostics.

Journal: Cancers

Published: March 20, 2022

Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma.

Targeted Analysis of Cell-free Circulating Tumor DNA is Suitable for Early Relapse and Actionable Target Detection in Patients with Neuroblastoma.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: October 20, 2021

Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction.

Multiplexed Quantification of Four Neuroblastoma DNA Targets in a Single Droplet Digital PCR Reaction.

Journal: The Journal of molecular diagnostics : JMD

Published: March 05, 2020

Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease model.

Reflection of neuroblastoma intratumor heterogeneity in the new OHC-NB1 disease model.

Journal: International journal of cancer

Published: March 26, 2019

Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma.

Using droplet digital PCR to analyze MYCN and ALK copy number in plasma from patients with neuroblastoma.

Journal: Oncotarget

Published: April 21, 2017

The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models.

The GSK461364 PLK1 inhibitor exhibits strong antitumoral activity in preclinical neuroblastoma models.

Journal: Oncotarget

Published: June 18, 2016

Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition.

Targeting MYCN-Driven Transcription By BET-Bromodomain Inhibition.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: June 25, 2015

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies.

A Cre-conditional MYCN-driven neuroblastoma mouse model as an improved tool for preclinical studies.

Journal: Oncogene

Published: October 24, 2013

The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma.

The KDM1A histone demethylase is a promising new target for the epigenetic therapy of medulloblastoma.

Journal: Acta neuropathologica communications

Published: May 07, 2013

Targeted expression of mutated ALK induces neuroblastoma in transgenic mice.

Targeted expression of mutated ALK induces neuroblastoma in transgenic mice.

Journal: Science translational medicine

Published: July 06, 2012

Showing 1-12 of 15

Last Updated: 09/26/2026